Related Experiment Videos
Pathogenesis of seronegative arthritis
British Journal of Rheumatology
|November 1, 1983
Summary
Seronegative spondarthritis, including ankylosing spondylitis, is linked to HLA-B27. Increased IgA antibodies in active patients suggest a role as an acute-phase reactant.
Area of Science:
- Immunology
- Rheumatology
- Genetics
Background:
- Seronegative spondarthritis encompasses diseases related to ankylosing spondylitis.
- Genetic factors, particularly HLA-B27, are strongly associated with these conditions.
- The role of exogenous factors like Klebsiella and diet remains unclear.
Purpose of the Study:
- To explore the genetic and potential exogenous factors in seronegative spondarthritis.
- To investigate the role of immunoglobulin A (IgA) in active ankylosing spondylitis.
Main Methods:
- Review of clinical and genetic data supporting the seronegative spondarthritis concept.
- Assessment of the influence of microbial and dietary factors.
- Measurement of serum and salivary IgA levels in patients with active ankylosing spondylitis.
Main Results:
- High frequency of HLA-B27 supports the genetic link in seronegative spondarthritis.
- Dietary interventions did not alter clinical disease manifestations.
- Elevated serum and salivary IgA antibodies were observed in active ankylosing spondylitis.
Conclusions:
- HLA-B27 is a significant genetic marker for seronegative spondarthritis.
- IgA may function as an acute-phase reactant in active ankylosing spondylitis.
- Further research is needed to clarify the role of exogenous factors.